{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:47:14Z","timestamp":1794019634213,"version":"4.8.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007080","name":"Ministry of Rural Affairs","doi-asserted-by":"publisher","award":["- 201920-NFST-TEL-01497"],"award-info":[{"award-number":["- 201920-NFST-TEL-01497"]}],"id":[{"id":"10.13039\/501100007080","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejmech.2023.115471","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T15:27:13Z","timestamp":1683559633000},"page":"115471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Molecular-level strategic goals and repressors in Leishmaniasis \u2013 Integrated data to accelerate target-based heterocyclic scaffolds"],"prefix":"10.1016","volume":"257","author":[{"given":"M.","family":"Abirami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banoth","family":"Karan Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samridhi","family":"Johri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondapalli Venkata","family":"Gowri Chandra Sekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3680-1577","authenticated-orcid":false,"given":"Murugesan","family":"Sankaranarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115471_bib1","series-title":"Control of the Leishmaniases","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.ejmech.2023.115471_bib2","series-title":"Global Leishmaniasis Surveillance, 2017\u20132018, and First Report on 5 Additional Indicators","year":"2020"},{"key":"10.1016\/j.ejmech.2023.115471_bib4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejmech.2023.115471_bib5","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00436-021-07139-2","article-title":"Leishmaniasis: where are we and where are we heading?","volume":"120","author":"Sasidharan","year":"2021","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2023.115471_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"Burza","year":"2018","journal-title":"Leishmaniasis, The Lancet"},{"key":"10.1016\/j.ejmech.2023.115471_bib7","series-title":"Cutaneous and Mucocutaneous Leishmaniasis","author":"Abad\u00edas-Granado","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115471_bib8","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research."},{"key":"10.1016\/j.ejmech.2023.115471_bib9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.12688\/f1000research.19056.4","article-title":"Orofacial manifestations of mucocutaneous leishmaniasis: a case series from Brazil","volume":"8","author":"Falc\u00e3o","year":"2020","journal-title":"F1000Research."},{"key":"10.1016\/j.ejmech.2023.115471_bib10","first-page":"309","volume":"vol. 26","author":"van Griensven","year":"2012"},{"key":"10.1016\/j.ejmech.2023.115471_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/HIV.S143929","article-title":"Visceral leishmaniasis and HIV coinfection: current perspectives","volume":"10","author":"Lindoso","year":"2018","journal-title":"HIV AIDS Res. Palliat. Care"},{"key":"10.1016\/j.ejmech.2023.115471_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0005877","article-title":"Post-kala-azar dermal leishmaniasis in the Indian subcontinent: a threat to the south-east asia region kala-azar elimination programme","volume":"11","author":"Zijlstra","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1008674","article-title":"The role of dermis resident macrophages and their interaction with neutrophils in the early establishment of Leishmania major infection transmitted by sand fly bite","volume":"16","author":"Chaves","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2023.115471_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2021.649348","article-title":"The impact of neutrophil recruitment to the skin on the pathology induced by leishmania infection","volume":"12","author":"Passelli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2023.115471_bib15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/jcp.30029","article-title":"Neutrophils and Visceral Leishmaniasis: impact on innate immune response and cross-talks with macrophages and dendritic cells","volume":"236","author":"Kupani","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2023.115471_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105173","article-title":"An overview of leishmanization experience: a successful control measure and a tool to evaluate candidate vaccines","volume":"200","author":"Mohebali","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2023.115471_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania vaccines entered in clinical trials: a review of literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.ejmech.2023.115471_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1515\/pac-2018-1102","article-title":"Current and promising novel drug candidates against visceral leishmaniasis","volume":"91","author":"Reguera","year":"2019","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/17425255.2019.1629417","article-title":"Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery\/development","volume":"15","author":"Sundar","year":"2019","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2023.115471_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.drudis.2019.03.007","article-title":"Walking a tightrope: drug discovery in visceral leishmaniasis","volume":"24","author":"Bala\u00f1a-Fouce","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115471_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2019.e00103","article-title":"Target Product Profile for a point-of-care diagnostic test for dermal leishmaniases","volume":"5","author":"Cruz","year":"2019","journal-title":"Parasite Epidemiology and Control"},{"key":"10.1016\/j.ejmech.2023.115471_bib22","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for Old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115471_bib23","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1074\/jbc.M005423200","article-title":"Novel intracellular SbV reducing activity correlates with antimony susceptibility in leishmania donovani","volume":"276","author":"Shaked-Mishan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib25","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fmicb.2021.638957","article-title":"Determinants of unresponsiveness to treatment in cutaneous leishmaniasis: a focus on anthroponotic form due to leishmania tropica","volume":"12","author":"Bamorovat","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115471_bib26","first-page":"106","article-title":"Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis","volume":"11","author":"Caridha","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115471_bib27","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/ijerph7124267","article-title":"Antimony toxicity","volume":"7","author":"Sundar","year":"2010","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.ejmech.2023.115471_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/AAC.01298-10","article-title":"High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in east africa and rationale for switch to liposomal amphotericin B","volume":"55","author":"Chappuis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/28.suppl_B.27","article-title":"Amphotericin B: an introduction","volume":"28","author":"Warnock","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.115471_bib31","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2023.115471_bib32","series-title":"Chemotherapeutics of Visceral Leishmaniasis : Present and Future Developments","first-page":"481","author":"Sundar","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115471_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-5173(88)90107-X","article-title":"A stability study of amphotericin B in aqueous media using factorial design","volume":"44","author":"Hung","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2023.115471_bib34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/1120009X.2017.1323150","article-title":"Visceral leishmaniosis in immunocompromised host: an update and literature review","volume":"29","author":"Pagliano","year":"2017","journal-title":"J. Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106459","article-title":"An update on the clinical pharmacology of miltefosine in the treatment of leishmaniasis","volume":"59","author":"Pali\u0107","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2023.115471_bib36","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-\u03b3-Dominated anti-leishmanial immune response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115471_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.6.8.1381","article-title":"Miltefosine to treat leishmaniasis","volume":"6","author":"Berman","year":"2005","journal-title":"Expet Opin. Pharmacother."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2023.115471_bib38","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2023.115471_bib39","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","article-title":"Optimal dosing of miltefosine in children and adults with visceral leishmaniasis","volume":"56","author":"Dorlo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib40","first-page":"1530","volume":"vol. 56","author":"Rijal","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115471_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","volume":"103","author":"Davidson","year":"2009","journal-title":"Paromomycin, Transactions of The Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.ejmech.2023.115471_bib42","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib43","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.115471_bib44","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0006-2952(96)00348-6","article-title":"Effects of cationic diamidines on polyamine content and uptake on Leishmania infantum in in vitro cultures","volume":"52","author":"Calonge","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib45","first-page":"925","article-title":"Interaction of cationic diamidines with Leishmania infantum DNA","volume":"379","author":"Johnson","year":"1998","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab065","article-title":"Efficacy and safety of pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review","volume":"28","author":"Piccica","year":"2021","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.ejmech.2023.115471_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203378","article-title":"Development and initial validation of a cutaneous leishmaniasis impact questionnaire","volume":"13","author":"Galv\u00e3o","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115471_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-6851(89)90026-1","article-title":"Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages","volume":"33","author":"Hart","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib49","doi-asserted-by":"crossref","first-page":"AAC0142521","DOI":"10.1128\/AAC.01425-21","article-title":"Potency and preclinical evidence of synergy of oral azole drugs and miltefosine in an ex vivo model of leishmania (viannia) panamensis infection","volume":"66","author":"Fern\u00e1ndez","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"Musa","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","article-title":"Chemotherapeutics of visceral leishmaniasis: present and future developments","volume":"145","author":"Sundar","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2023.115471_bib53","article-title":"Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis","author":"Van Bocxlaer","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115471_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2014.04.003","article-title":"Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects","volume":"30","author":"Patterson","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib55","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/acsinfecdis.1c00139","article-title":"Ex vivo phenotypic screening of two small repurposing drug collections identifies nifuratel as a potential new treatment against visceral and cutaneous leishmaniasis","volume":"7","author":"Dom\u00ednguez-Asenjo","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2023.115471_bib57","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1021\/acs.jmedchem.7b00034","article-title":"7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1- b ][1,3]oxazines: novel antitubercular agents lead to a new preclinical candidate for visceral leishmaniasis","volume":"60","author":"Thompson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib58","first-page":"6185","article-title":"Spotlight on tavaborole for the treatment of onychomycosis","volume":"9","author":"Jinna","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2023.115471_bib59","series-title":"Portfolio DNDi","author":"Drugs for Neglected Diseases initiative","year":"2020"},{"key":"10.1016\/j.ejmech.2023.115471_bib60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115471_bib61","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1021\/acs.jmedchem.1c00047","article-title":"Scaffold-hopping strategy on a series of proteasome inhibitors led to a preclinical candidate for the treatment of visceral leishmaniasis","volume":"64","author":"Thomas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib62","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.jmedchem.8b01218","article-title":"Identification of gsk3186899\/ddd853651 as a preclinical development candidate for the treatment of visceral leishmaniasis","volume":"62","author":"Thomas","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115471_bib64","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib65","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.115471_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008050","article-title":"CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis","volume":"14","author":"Thacker","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib67","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/1521-4141(200209)32:9<2617::AID-IMMU2617>3.0.CO;2-F","article-title":"CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells","volume":"32","author":"Gursel","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115471_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4155\/fmc.09.147","article-title":"Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics","volume":"2","author":"Braun-Sand","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molbiopara.2011.08.006","article-title":"Molecular & Biochemical Parasitology Short communication IMP dehydrogenase deficiency in Leishmania donovani causes a restrictive growth phenotype in promastigotes but is not essential for infection in mice","volume":"180","author":"Fulwiler","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib70","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115471_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejmech.2023.115471_bib72","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molbiopara.2016.06.008","article-title":"Molecular & Biochemical Parasitology GMP reductase and genetic uncoupling of adenylate and guanylate metabolism in Leishmania donovani parasites","volume":"208","author":"Boitz","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pep.2016.11.004","article-title":"The expression of NTPDase1 and -2 of Leishmania infantum chagasi in bacterial and mammalian cells: comparative expression, refolding and nucleotidase characterization","volume":"131","author":"Bastos","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejmech.2023.115471_bib74","doi-asserted-by":"crossref","first-page":"18681","DOI":"10.1074\/jbc.TM118.006291","article-title":"Introduction to the thematic minireview series: sixty plus years of polyamine research","volume":"293","author":"Pegg","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib75","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine metabolism and cancer: treatments, challenges and opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115471_bib76","doi-asserted-by":"crossref","first-page":"18746","DOI":"10.1074\/jbc.TM118.003342","article-title":"Polyamines in protozoan pathogens","volume":"293","author":"Phillips","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006025","article-title":"L-arginine availability and arginase activity: characterization of amino acid permease 3 in Leishmania amazonensis","volume":"11","author":"Aoki","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0166-6851(95)00042-Y","article-title":"Kinetics and molecular characteristics of arginine transport by Leishmania donovani promastigotes","volume":"71","author":"Kandpal","year":"1995","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2006.11.013","article-title":"S-Adenosylmethionine in protozoan parasites: functions, synthesis and regulation","volume":"152","author":"Reguera","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib80","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1042\/bst0310411","article-title":"Turnover of trypanosomal ornithine decarboxylases","volume":"31","author":"Persson","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2023.115471_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00554-16","article-title":"Arginase is essential for survival of Leishmania donovani promastigotes but not intracellular amastigotes","volume":"85","author":"Boitz","year":"2017","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2023.115471_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molbiopara.2009.01.001","article-title":"Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB\/c mice","volume":"165","author":"Reguera","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molbiopara.2011.10.007","article-title":"Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis","volume":"181","author":"Bala\u00f1a-Fouce","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib84","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.abb.2013.03.015","article-title":"Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections","volume":"535","author":"D'Antonio","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2023.115471_bib85","doi-asserted-by":"crossref","first-page":"14529","DOI":"10.1074\/jbc.R500031200","article-title":"Regulation of ornithine decarboxylase","volume":"281","author":"Pegg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cca.2005.02.006","article-title":"Polyamine transport in parasites: a potential target for new antiparasitic drug development","volume":"140","author":"Reguera","year":"2005","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib87","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.01236-08","article-title":"Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host","volume":"77","author":"Jan","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2023.115471_bib88","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0024-3205(94)00916-3","article-title":"Fluorinated analogues of L-ornithine are powerful inhibitors of ornithine decarboxylase and cell growth of Leishmania infantum promastigotes","volume":"56","author":"Reguera","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2023.115471_bib89","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/bbrc.2000.3996","article-title":"Sensitivity of trypanosomatid Protozoa to DFMO and metabolic turnover of ornithine decarboxylase","volume":"279","author":"Carrillo","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115471_bib90","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/cbdd.12665","article-title":"Novel inhibitors of ornithine decarboxylase of leishmania parasite (ld ODC): the parasite resists ld ODC inhibition by overexpression of spermidine synthase","volume":"87","author":"Das","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115471_bib91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0014-5793(99)00804-2","article-title":"Trypanosoma cruzi epimastigotes lack ornithine decarboxylase but can express a foreign gene encoding this enzyme","volume":"454","author":"Carrillo","year":"1999","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.ejmech.2023.115471_bib92","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000074548","article-title":"Proteasomal degradation of a trypanosomal ornithine decarboxylase","volume":"13","author":"Nasizadeh","year":"2003","journal-title":"Cell. Physiol. Biochem. : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10.1016\/j.ejmech.2023.115471_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006201.pub3","article-title":"Chemotherapy for second-stage human African trypanosomiasis","author":"Lutje","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2023.115471_bib94","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00726-007-0537-9","article-title":"Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis","volume":"33","author":"Heby","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2023.115471_bib95","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2014.12.008","article-title":"Novel protein-protein interaction between spermidine synthase and S-adenosylmethionine decarboxylase from Leishmania donovani","volume":"456","author":"Mishra","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115471_bib96","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/phrs.1996.0011","article-title":"Antileishmanial effect of a potent S-adenosylmethionine decarboxylase inhibitor: cgp 40215A","volume":"33","author":"Mukhopadhyay","year":"1996","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2023.115471_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/1357-2725(95)93432-P","article-title":"Antileishmanial activity of berenil and methylglyoxal bis (guanylhydrazone) and its correlation with S-adenosylmethionine decarboxylase and polyamines","volume":"27","author":"Mukhopadhyay","year":"1995","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115471_bib98","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/j.bmcl.2009.04.096","article-title":"Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT)","volume":"19","author":"Hirth","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115471_bib99","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.bmc.2017.07.063","article-title":"Synthesis and evaluation of analogs of 5\u2019-(((Z)-4-amino-2-butenyl)methylamino)-5\u2019-deoxyadenosine (MDL 73811, or AbeAdo) - an inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity","volume":"25","author":"Brockway","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib100","doi-asserted-by":"crossref","unstructured":"I.A. Rodrigues, A.R. Garcia, M.M. Paz, R.G.D. Grilo Junior, A.C.F. Amaral, A.S. Pinheiro, Polyamine and Trypanothione Pathways as Targets for Novel Antileishmanial Drugs, in: Springer Berlin Heidelberg, Berlin, Heidelberg, n.d.: pp. 1\u201338. https:\/\/doi.org\/10.1007\/7355_2021_139.","DOI":"10.1007\/7355_2021_139"},{"key":"10.1016\/j.ejmech.2023.115471_bib101","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1126\/science.3883489","article-title":"Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids","volume":"227","author":"Fairlamb","year":"1985","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2023.115471_bib102","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bbagen.2015.05.022","article-title":"Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase","volume":"1850","author":"Angiulli","year":"2015","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2023.115471_bib103","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1080\/07391102.2015.1085904","article-title":"Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach","volume":"33","author":"Pandey","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115471_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25081924","article-title":"Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases","volume":"25","author":"Battista","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115471_bib105","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbagen.2016.06.005","article-title":"Biochimica et Biophysica Acta Leishmania donovani Aurora kinase : a promising therapeutic target against visceral leishmaniasis","volume":"1860","author":"Chhajer","year":"2016","journal-title":"BBA - General Subjects"},{"key":"10.1016\/j.ejmech.2023.115471_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008167","article-title":"Epigenetic regulation of defense genes by histone deacetylase 1 in human cell linederived macrophages promotes intracellular survival of leishmania donovani","volume":"14","author":"Roy","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molbiopara.2011.08.005","article-title":"Leishmania donovani encodes a functional enzyme involved in vitamin c biosynthesis: arabino-1,4-lactone oxidase","volume":"180","author":"Biyani","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib108","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115471_bib109","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1054-3589(08)60540-2","article-title":"Mechanism of catalysis by eukaryotic DNA topoisomerase I","volume":"29A","author":"Champoux","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2023.115471_bib111","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/nar\/gkn1009","article-title":"Structural studies of type I topoisomerases","volume":"37","author":"Baker","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115471_bib112","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2608","article-title":"DNA topoisomerase II and its growing repertoire of biological functions","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115471_bib113","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib114","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpddr.2014.07.006","article-title":"Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery","volume":"4","author":"Bala\u00f1a-Fouce","year":"2014","journal-title":"International Journal for Parasitology. Drugs and Drug Resistance"},{"key":"10.1016\/j.ejmech.2023.115471_bib115","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bcp.2008.06.019","article-title":"Mutational study of the \u201ccatalytic tetrad\u201d of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: role of Asp-353 and Asn-221 in camptothecin resistance","volume":"76","author":"Diaz-Gonz\u00e1lez","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib116","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbrc.2021.07.019","article-title":"Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits","volume":"569","author":"Lee","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115471_bib117","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.bcp.2013.02.024","article-title":"Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect","volume":"85","author":"Prada","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/AAC.00650-07","article-title":"Activity of indenoisoquinolines against african trypanosomes","volume":"53","author":"B.R","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib119","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.exppara.2007.02.018","article-title":"Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine","volume":"116","author":"Cort\u00e1zar","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/np400717m","article-title":"Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems","volume":"77","author":"De Sousa","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115471_bib121","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/acs.jnatprod.5b00875","article-title":"Verbascoside inhibits promastigote growth and arginase activity of leishmania amazonensis","volume":"79","author":"Maquiaveli","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115471_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2020.624678","article-title":"Identification of chalcone derivatives as inhibitors of leishmania infantum arginase and promising antileishmanial agents","volume":"8","author":"Garcia","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib123","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.foodchem.2013.05.025","article-title":"Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection","volume":"141","author":"Manjolin","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib124","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cbdd.13391","article-title":"Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase","volume":"93","author":"da Silva","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2023.115471_bib125","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1016\/j.bmc.2019.07.022","article-title":"Phenylhydrazides as inhibitors of Leishmania amazonensis arginase and antileishmanial activity","volume":"27","author":"Crizanto de Lima","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078387","article-title":"Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG, (+)-catechin and (-)-epicatechin: a comparative structural analysis of enzyme-inhibitor interactions","volume":"8","author":"Dos Reis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115471_bib127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.phytochem.2013.01.014","article-title":"Leishmanicidal activity of Cecropia pachystachya flavonoids: arginase inhibition and altered mitochondrial DNA arrangement","volume":"89","author":"Cruz","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2023.115471_bib128","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.exppara.2013.07.021","article-title":"Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani","volume":"135","author":"Hazra","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib129","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/07391102.2018.1439772","article-title":"Virtual screening of natural inhibitors targeting ornithine decarboxylase with pharmacophore scaffolding of DFMO and validation by molecular dynamics simulation studies","volume":"37","author":"Sivashanmugam","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115471_bib130","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.bbapap.2012.05.016","article-title":"A leishmaniasis study: structure-based screening and molecular dynamics mechanistic analysis for discovering potent inhibitors of spermidine synthase","volume":"1824","author":"Grover","year":"2012","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejmech.2023.115471_bib131","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1080\/07391102.2017.1366947","article-title":"Identification of two natural compound inhibitors of Leishmania donovani Spermidine Synthase (SpdS) through molecular docking and dynamic studies","volume":"36","author":"V. V","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115471_bib132","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00018-017-2653-3","article-title":"Ammonium trichloro [1,2-ethanediolato-O,O\u2032]-tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K\/Akt pathway","volume":"75","author":"Vishwakarma","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2023.115471_bib133","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1021\/acs.molpharmaceut.8b00185","article-title":"Toward a drug against all kinetoplastids: from LeishBox to specific and potent trypanothione reductase inhibitors","volume":"15","author":"Ilari","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2023.115471_bib134","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00436-014-3850-8","article-title":"Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives","volume":"113","author":"Villalobos-Rocha","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2023.115471_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00590-21","article-title":"New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase","volume":"65","author":"Etxebeste-Mitxeltorena","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib136","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/07391102.2015.1135298","article-title":"Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation","volume":"35","author":"Pandey","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115471_bib137","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.bmc.2012.01.009","article-title":"Investigation of trypanothione reductase inhibitory activity by 1,3,4-thiadiazolium-2-aminide derivatives and molecular docking studies","volume":"20","author":"Rodrigues","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib138","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/2211352518666200131121308","article-title":"Novel scaffolds for leishmania infantum trypanothione reductase inhibitors derived from Brazilian natural products biodiversity","volume":"18","author":"da Paix\u00e3o","year":"2020","journal-title":"Anti-Infective Agents"},{"key":"10.1016\/j.ejmech.2023.115471_bib139","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.bmcl.2017.03.049","article-title":"Anti-leishmanial and cytotoxic activities of amino acid-triazole hybrids: synthesis, biological evaluation, molecular docking and in silico physico-chemical properties","volume":"27","author":"Masood","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115471_bib140","doi-asserted-by":"crossref","first-page":"FDD41","DOI":"10.4155\/fdd-2020-0002","article-title":"Antileishmanial effects of Sargassum vulgare products and prediction of trypanothione reductase inhibition by fucosterol","volume":"2","author":"Tchokouaha Yamthe","year":"2020","journal-title":"Future Drug Discovery"},{"key":"10.1016\/j.ejmech.2023.115471_bib141","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejpb.2013.08.014","article-title":"Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen","volume":"85","author":"Saudagar","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2023.115471_bib142","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/cmdc.201300176","article-title":"Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by x-ray crystallography","volume":"8","author":"Baiocco","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115471_bib143","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2023.115471_bib144","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11010-011-0762-0","article-title":"Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis","volume":"352","author":"Shukla","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2023.115471_bib145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1039\/C4MD00298A","article-title":"Novel \u03b2-carboline-quinazolinone hybrid as an inhibitor of Leishmania donovani trypanothione reductase: synthesis, molecular docking and bioevaluation","volume":"6","author":"Chauhan","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2023.115471_bib146","doi-asserted-by":"crossref","DOI":"10.22270\/ujpr.v4i3.268","article-title":"Coumarin analogues as a potential inhibitor of leishmaniasis: a multi-targeting protein inhibition approach by molecular docking","author":"Kapoor","year":"2019","journal-title":"Universal Journal of Pharmaceutical Research"},{"key":"10.1016\/j.ejmech.2023.115471_bib147","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/14756366.2016.1250755","article-title":"Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives","volume":"32","author":"Saccoliti","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib148","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/ml1002629","article-title":"Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation","volume":"2","author":"Baiocco","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115471_bib149","first-page":"133","article-title":"Molecular docking based inhibition of Trypanothione reductase activity by Taxifolin novel target for antileishmanial activity","volume":"2","author":"Gundampati","year":"2012","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.115471_bib150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmech.2018.02.071","article-title":"Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled \u03b1-helical peptides with improved proteolytic stability","volume":"149","author":"Ruiz-Santaquiteria","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib151","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/10799893.2016.1171344","article-title":"Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase","volume":"37","author":"Pandey","year":"2017","journal-title":"J. Recept. Signal Transduction"},{"key":"10.1016\/j.ejmech.2023.115471_bib152","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1080\/07391102.2020.1721330","article-title":"Identification of potential anti-leishmanial agents using computational investigation and biological evaluation against trypanothione reductase","volume":"39","author":"Kuldeep","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115471_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-019-1826-1","article-title":"Natural compounds from plants controlling leishmanial growth via DNA damage and inhibiting trypanothione reductase and trypanothione synthetase: an in vitro and in silico approach","volume":"9","author":"Mehwish","year":"2019","journal-title":"3 Biotech"},{"key":"10.1016\/j.ejmech.2023.115471_bib154","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/acsinfecdis.9b00505","article-title":"Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors","volume":"6","author":"Tunes","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib155","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acsinfecdis.8b00355","article-title":"Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in nonpeptidic dimerization inhibitors of leishmania infantum trypanothione reductase","volume":"5","author":"Revuelto","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib156","doi-asserted-by":"crossref","first-page":"15621","DOI":"10.1021\/acs.jmedchem.0c00690","article-title":"Targeting the trypanothione reductase of tissue-residing leishmania in hosts' reticuloendothelial system: a flexible water-soluble ferrocenylquinoline-based preclinical drug candidate","volume":"63","author":"Mukherjee","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183216","article-title":"Leishmania mexicana trypanothione reductase inhibitors: computational and biological studies","volume":"24","author":"Matadamas-Mart\u00ednez","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115471_bib158","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2018.04.057","article-title":"Identification of chalcone-based antileishmanial agents targeting trypanothione reductase","volume":"152","author":"Ortalli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-77066-2","article-title":"Bioassay-based Corchorus capsularis L. leaf-derived \u03b2-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase","volume":"10","author":"Pramanik","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115471_bib160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2217\/nnm-2017-0255","article-title":"Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis","volume":"13","author":"Sarwar","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejmech.2023.115471_bib161","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.phymed.2015.08.012","article-title":"Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae)","volume":"22","author":"Lima","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2023.115471_bib162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006969","article-title":"Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening","volume":"12","author":"Turcano","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115471_bib163","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1080\/07391102.2018.1502096","article-title":"Insights about resveratrol analogs against trypanothione reductase of Leishmania braziliensis: molecular modeling, computational docking and in vitro antileishmanial studies","volume":"37","author":"da Silva","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115471_bib164","article-title":"A lupane-triterpene isolated from Combretum leprosum Mart. fruit extracts that interferes with the intracellular development of Leishmania (L.) amazonensis in vitro","volume":"15","author":"Teles","year":"2015","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.ejmech.2023.115471_bib165","first-page":"1","article-title":"The effect of 3\u03b2, 6\u03b2, 16\u03b2-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells","volume":"15","author":"Lacouth-Silva","year":"2015","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.ejmech.2023.115471_bib166","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exppara.2017.02.010","article-title":"Copper salisylaldoxime (CuSAL) imparts protective efficacy against visceral leishmaniasis by targeting Leishmania donovani topoisomerase IB","volume":"175","author":"Singh","year":"2017","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115471_bib167","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1016\/j.bmcl.2012.08.019","article-title":"2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani","volume":"22","author":"Carballeira","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115471_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028493","article-title":"Development of derivatives of 3, 3\u2032-diindolylmethane as potent Leishmania donovani Bi-subunit topoisomerase IB poisons","volume":"6","author":"Roy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115471_bib169","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/mol.111.072785","article-title":"Novel betulin derivatives as antileishmanial agents with mode of action targeting type IB DNA topoisomerase","volume":"80","author":"Chowdhury","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1876518101103010023","article-title":"Conjugated eicosapentaenoic acid (cEPA) inhibits L. Donovani topoisomerase I and has an antiproliferative activity against L. Donovani promastigotes","volume":"3","author":"Desideri","year":"2011","journal-title":"Open Antimicrob. Agents J."},{"key":"10.1016\/j.ejmech.2023.115471_bib171","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.parint.2015.06.011","article-title":"In vitro activity of synthetic tetrahydroindeno[2,1-c]quinolines on Leishmania mexicana","volume":"64","author":"Hern\u00e1ndez-Chinea","year":"2015","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2023.115471_bib172","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.fitote.2015.11.021","article-title":"A new bisbenzylisoquinoline alkaloid isolated from Thalictrum foliolosum, as a potent inhibitor of DNA topoisomerase IB of Leishmania donovani","volume":"109","author":"Kumar","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2023.115471_bib173","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/emmm.201201316","article-title":"The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice","volume":"4","author":"Chowdhury","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2023.115471_bib174","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bcp.2017.05.002","article-title":"Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB","volume":"138","author":"Chowdhury","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib175","first-page":"70","article-title":"Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB","volume":"11","author":"P\u00e9rez-Pertejo","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115471_bib176","first-page":"1","article-title":"Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors","volume":"6","author":"Mamidala","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115471_bib177","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1017\/S0031182008005180","article-title":"9-O-acetylated sialic acids enhance entry of virulent Leishmania donovani promastigotes into macrophages","volume":"136","author":"Ghoshal","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2023.115471_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.70","article-title":"Isobenzofuranone derivatives exhibit antileishmanial effect by inhibiting type II DNA topoisomerase and inducing host response","volume":"2","author":"Mishra","year":"2014","journal-title":"Pharmacology Research and Perspectives"},{"key":"10.1016\/j.ejmech.2023.115471_bib179","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0034-1382826","article-title":"In vitro and in vivo activity of benzo[ c ]phenanthridines against Leishmania amazonensis","volume":"80","author":"Castillo","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2023.115471_bib180","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.3390\/molecules190915180","article-title":"Synthesis, leishmanicidal activity and theoretical evaluations of a series of substituted bis-2-Hydroxy-1,4-Naphthoquinones","volume":"19","author":"De Ara\u00fajo","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115471_bib181","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00688-17","article-title":"Efficacy of a binuclear cyclopalladated compound therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on topoisomerase 1B","volume":"61","author":"Vel\u00e1squez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115471_bib182","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ejmech.2016.09.017","article-title":"Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase","volume":"124","author":"Tejer\u00eda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115471_bib183","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2013.10.004","article-title":"The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo","volume":"86","author":"Saha","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115471_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102287","article-title":"The HIV \u2212 1 protease inhibitor Amprenavir targets Leishmania donovani topoisomerase I and induces oxidative stress-mediated programmed cell death","volume":"82","author":"Roy","year":"2021","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ejmech.2023.115471_bib185","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1128\/AAC.00499-12","article-title":"Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis","volume":"56","author":"Balan\u00e3-Fouce","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T14:52:06Z","timestamp":1730991126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423004373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":183,"alternative-id":["S0223523423004373"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115471","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular-level strategic goals and repressors in Leishmaniasis \u2013 Integrated data to accelerate target-based heterocyclic scaffolds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115471"}}